Glenbrook Capital Management Discloses New 8.33% Stake in INVO Fertility, Inc.

Glenbrook Capital Management (GCM) has filed a Schedule 13G disclosing a new 8.33% stake in INVO Fertility, Inc. (IVF). As of the event date on March 25, 2026, the Nevada-based investment manager reported beneficial ownership of 134,515 shares of Common Stock. This position was established from a previous zero-holding status, crossing the 5% regulatory reporting threshold. The investment is managed by a committee consisting of Grover T. Wickersham, Richard Rudgley, and Robert W. Lishman, who serve as the investment manager to various funds holding the shares. The percentage of ownership is based on 1,615,419 shares of Common Stock outstanding as reported by the issuer. The filing was made under Rule 13d-1(c), indicating a passive investment intent. GCM maintains shared voting and dispositive power over the entire reported position. This filing highlights a significant new institutional interest in the medical technology firm specializing in fertility treatments.